Home » An open-label, randomised, phase III study comparing trifluridine/tipiracil in combination with bevacizumab to trifluridine/tipiracil monotherapy in patients with refractory metastatic colorectal cancer » [CL3-95005-007]-laysummary-final-2024.02.02.en